Skip to content
Toggle main navigation
More
Open dropdown to see remaining menu items
Log in
Select an available language
EN
Is Vanguard Target Retirement 2030 Fund (VTHRX) a Strong Mutual Fund Pick Right Now?
Published on January 6, 2022
Mutual Fund Report for VTHRX
Continue reading on website
Other news
Is Fidelity Emerging Asia Fund (FSEAX) a Strong Mutual Fund Pick Right Now?
January 6, 2022
Mutual Fund Report for FSEAX
‘How can you understand life if you don’t look at it live?’ — Eikon Therapeutics rakes in $518M
January 6, 2022
Adam Goulburn, a partner at Lux Capital, was first struck by Eikon Therapeutics’ pitch to use super microscopes to develop drugs when founder Eric Betzig posed a simple question: How can you understand life if you don’t look at it live? “It was such a simple statement, but it was kind of eye opening to me,” Goulburn tells TechCrunch.The environment within our cells is in perpetual motion: proteins